In breast cancer, NAC has been well documented to significantly reduce tumour- infiltrating FOXP3+, CTLA-4+ and PD-1+ T cells (but not CD8+ T cells) [60, 61, 38, 25, 13]. The gene discussed is FOXP3; the disease is breast carcinoma.